Can we Really use Viruses to Treat Prostate Cancer?

Presenter: Dr. Jean-Simon Diallo
Original Date: Tuesday, April 5, 2016

Join Dr. Diallo to learn about: 

  • Basic cancer biology
  • Oncolytic virotherapy and oncolytic vaccines
  • Prostate cancer progression/treatment
  • How we are aiming to treat prostate cancer using our novel oncolytic vaccine approach

Dr. Jean-Simon Diallo's Biography:

Dr. Jean-Simon Diallo obtained his Master’s degree in Biochemistry at McGill University and his Ph.D in molecular biology at the Université de Montréal, where he studied natural compounds to treat prostate cancer and bio-markers to predict prostate cancer outcome. During his postdoctoral fellowship, Dr. Diallo worked on using oncolytic viruses to treat cancer and discovered a host of “viral sensitizer” molecules that enhance viral infection. Since 2012, he has been a Scientist at the Ottawa Hospital Research Institute. Working within a national network of collaborators, he and his team are working to improve virus-based therapeutics for the treatment of cancer and other diseases, by combining them with an increasing collection of novel “viral sensitizer” small molecules.

Expert AngleAbout Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.


Prostate Cancer Awareness Month

Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.

Click here for news archive